DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Batchelor TT, Sorensen AG, di Tomaso E. , et al.
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
Cancer Cell 2007;
11 (01) 83-95
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.